Presented by CVS Health: Delivered every Tuesday and Friday by 12 p.m., Prescription Pulse examines the latest pharmaceutical news and policy. Mar 19… Read More
Presented by the Coalition for Affordable Prescription Drugs: Delivered every Tuesday and Friday by 12 p.m., Prescription Pulse examines the latest pharmaceutical news and policy… Read More
The American biopharmaceutical company receives marketing authorisation for the drug through Project Orbis
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has approv… Read More
(NewMediaWire) – December 11, 2023 – DALLAS — The American Heart Association — the world’s leading voluntary organization dedicated to a world of longer, he… Read More
PHILADELPHIA — The symptoms of stable angina can be eased by percutaneous coronary intervention (PCI) alone in the absence of antianginal medications, the randomized ORBITA-2 trial… Read More
A regimen of pre-surgical immunotherapy and chemotherapy followed by post-surgical immunotherapy significantly improved event-free survival (EFS) and pathologic complete… Read More
Filing a legal claim against another party may be intimidating; legal fees can be expensive, and it may take a long time for your case to be heard by a judge and/or jury. However, this is wh… Read More
Immunosuppressant drugs is estimated to be valued at US$ XX million in
2022 and is expected to exhibit a CAGR of XX% over the forecast period
(2023-2030), as highlighted in a new repor… Read More
The global myelodysplastic syndrome (MDS) treatment market is expected to grow significantly over the forecast period, owing to the increasing pipeline products and product approvals and R&a… Read More
Company Has Now Satisfied All Regulatory Approvals for Celgene Acquisition Transaction Expected to Close on November 20, 2019 FTC Approves Agreement between Celgene and Amgen to Divest OTEZL… Read More
Bristol Myers Squibb (BMS) was granted US Food and Drug Administration (FDA) approval for its highly awaited cardiac drug Camzyos (mavacamten) for the treatment of symptomatic obstructive hy… Read More
The new FDA approval gives Breyanzi (lisocabtagene maraleucel) the broadest patient eligibility of any CAR T-cell therapy in relapsed or refractory LBCL. Product logo and product image court… Read More
Checking in with your stocks about once a year seems like the minimum cadence for a long-term tech investor. In reality, you’ll be checking in more often when dramatic stock price mo… Read More
Market Highlights:
Thoracic outlet syndrome is the compression of the neurovascular structures caused due to weight lifting, tumors in the chest, bone abnormalities, trauma, and others… Read More
Market Highlights:
Thoracic outlet syndrome is the compression of the neurovascular structures caused due to weight lifting, tumors in the chest, bone abnormalities, trauma, and others… Read More
MRFR offering latest study report on Thoracic Outlet Syndrome Market Research Report Information: By Type (Neurogenic, Venous, Arterial Thoracic Outlet Syndrome) Diagnosis (Ct Scan, Mri Scan… Read More
The post Inhibiting Enzyme Helps Cancer Immunotherapy Work Better appeared first on TodayHeadline.
Most cancers immunotherapy — a remedy that higher permits a affected person’… Read More
Mucormycosis (zygomycosis) is a serious but rare fungal infection caused by a group of molds called mucormycetes. Moreover, inhaling fungal spores from the air can affect the lungs and sinus… Read More
A proposal to sharply cut a drug discount program that many hospitals rely on drew some 1,400 comments when the Trump administration announced its plan last year. Hundreds appeared to come… Read More
A growing number of small clinical trials have demonstrated that subanesthetic doses of ketamine can produce antidepressant effects in patients with mood disorders who have demonstrated ref… Read More